{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:02:55Z","timestamp":1768035775683,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anai.2021.02.011","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:09:07Z","timestamp":1613434147000},"page":"725-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The use of intravenous tranexamic acid for patients with angiotensin-converting enzyme inhibitor\u2013induced angioedema"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5688-9692","authenticated-orcid":false,"given":"Jose Manuel","family":"Martinez Manzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Bryan","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Patarroyo-Aponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zurab","family":"Azmaiparashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anai.2021.02.011_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0196-0644(84)80043-8","article-title":"Captopril-induced angioedema","volume":"13","author":"Jett","year":"1984","journal-title":"Ann Emerg Med"},{"issue":"8","key":"10.1016\/j.anai.2021.02.011_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2021.02.011_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000368404","article-title":"Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting","volume":"165","author":"Craig","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.02.011_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jemermed.2017.05.037","article-title":"Novel therapies for angiotensin-converting enzyme inhibitor\u2013induced angioedema: a systematic review of current evidence","volume":"53","author":"Riha","year":"2017","journal-title":"J\u00a0Emerg Med"},{"issue":"8","key":"10.1016\/j.anai.2021.02.011_bib5","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.anai.2021.02.011_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.revmed.2018.04.014","article-title":"Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors","volume":"39","author":"Beauch\u00eane","year":"2018","journal-title":"Rev Med Interne"},{"issue":"4","key":"10.1016\/j.anai.2021.02.011_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","article-title":"Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"14","key":"10.1016\/j.anai.2021.02.011_bib8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril","volume":"165","author":"Kostis","year":"2005","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.anai.2021.02.011_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-6749(96)70151-3","article-title":"Increased sensitivity to bradykinin among African Americans","volume":"98","author":"Gainer","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.02.011_bib10","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jaci.2015.07.041","article-title":"Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels","volume":"137","author":"Joseph","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:26:25Z","timestamp":1761053185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1081120621001290"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.02.011","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of intravenous tranexamic acid for patients with angiotensin-converting enzyme inhibitor\u2013induced angioedema","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}